{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:41:24Z","timestamp":1758282084526,"version":"3.44.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.atherosclerosis.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T10:36:40Z","timestamp":1551523000000},"page":"262-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reply to: \u201cThe \u201ccholesterol paradox\u201d in patients with mastocytosis\u201d"],"prefix":"10.1016","volume":"284","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-1959","authenticated-orcid":false,"given":"Ilze","family":"Bot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique T.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swasti","family":"Indhirajanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.A.","family":"van Daele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine E.","family":"Roeters van Lennep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2019.01.019","article-title":"The \u201ccholesterol paradox\u201d in patients with mastocytosis","author":"Femin\u00f2","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.atherosclerosis.2017.11.030","article-title":"Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levels","volume":"268","author":"Indhirajanti","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/clc.22864","article-title":"Lipid profile and incidence of atrial fibrillation: a prospective cohort study in China","volume":"41","author":"Li","year":"2018","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ni.2109","article-title":"Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils","volume":"12","author":"Galli","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib5","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.106.660472","article-title":"Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice","volume":"115","author":"Bot","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060960","article-title":"Tryptase promotes atherosclerotic plaque haemorrhage in ApoE-\/- mice","volume":"8","author":"Zhi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cvr\/cvq260","article-title":"Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-\/- mice","volume":"89","author":"Bot","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib8","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/eurheartj\/eht186","article-title":"Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events","volume":"34","author":"Willems","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/ATVBAHA.115.306827","article-title":"Carboxyl-terminal cleavage of apolipoprotein A-I by human mast cell chymase impairs its anti-inflammatory properties","volume":"36","author":"Nguyen","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib10","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.bbadis.2014.07.026","article-title":"Cathepsin G activity lowers plasma LDL and reduces atherosclerosis","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.02.018_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2018.04.016","article-title":"Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding","volume":"275","author":"Maaninka","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019301042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019301042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:40:33Z","timestamp":1758156033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019301042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":11,"alternative-id":["S0021915019301042"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to: \u201cThe \u201ccholesterol paradox\u201d in patients with mastocytosis\u201d","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.11.030","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}